Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany.
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
Diabetes Care. 2023 Dec 1;46(12):2232-2239. doi: 10.2337/dc23-1267.
Diabetes may feature impaired insulin kinetics, which could be aggravated by altered hepatic metabolism and glycemic control. Thus, we examined insulin clearance and its possible determinants in individuals with recent-onset diabetes.
Participants of the German Diabetes Study (GDS) with type 1 diabetes (T1D) (n = 306), type 2 diabetes (T2D) (n = 489), or normal glucose tolerance (control [CON]) (n = 167) underwent hyperinsulinemic-euglycemic clamps for assessment of whole-body insulin sensitivity (M value) and insulin clearance (ICCLAMP). Insulin clearance rates were further calculated during intravenous glucose tolerance tests (ICIVGTT) and mixed-meal tests (ICMMT). Hepatocellular lipid content (HCL) was quantified with 1H-MRS.
Both T1D and T2D groups had lower ICCLAMP (0.12 ± 0.07 and 0.21 ± 0.06 vs. 0.28 ± 0.14 arbitrary units [a.u.], respectively, all P < 0.05) and ICMMT (0.71 ± 0.35 and 0.99 ± 0.33 vs. 1.20 ± 0.36 a.u., all P < 0.05) than CON. In T1D, ICCLAMP, ICIVGTT, and ICMMT correlated negatively with HbA1c (all P < 0.05). M value correlated positively with ICIVGTT in CON and T2D (r = 0.199 and r = 0.178, P < 0.05) and with ICMMT in CON (r = 0.176, P < 0.05). HCL negatively associated with ICIVGTT and ICMMT in T2D (r = -0.005 and r = -0.037) and CON (r = -0.127 and r = -0.058, all P < 0.05). In line, T2D or CON subjects with steatosis featured lower ICMMT than those without steatosis (both P < 0.05).
Insulin clearance is reduced in both T1D and T2D within the first year after diagnosis but correlates negatively with liver lipid content rather in T2D. Moreover, insulin clearance differently associates with glycemic control and insulin sensitivity in each diabetes type, which may suggest specific mechanisms affecting insulin kinetics.
糖尿病可能存在胰岛素动力学受损,而肝代谢和血糖控制的改变可能会加重这种情况。因此,我们研究了新发糖尿病患者的胰岛素清除率及其可能的决定因素。
德国糖尿病研究(GDS)中的参与者包括 1 型糖尿病(T1D)(n=306)、2 型糖尿病(T2D)(n=489)或正常葡萄糖耐量(对照组 [CON])(n=167),他们接受了高胰岛素-正常血糖钳夹试验以评估全身胰岛素敏感性(M 值)和胰岛素清除率(ICCLAMP)。胰岛素清除率在静脉葡萄糖耐量试验(ICIVGTT)和混合餐试验(ICMMT)期间进一步计算。使用 1H-MRS 定量肝内脂质含量(HCL)。
T1D 和 T2D 组的 ICCLAMP(分别为 0.12±0.07 和 0.21±0.06 与 0.28±0.14 任意单位[a.u.],均 P<0.05)和 ICMMT(分别为 0.71±0.35 和 0.99±0.33 与 1.20±0.36 a.u.,均 P<0.05)均低于 CON。在 T1D 中,ICCLAMP、ICIVGTT 和 ICMMT 与 HbA1c 呈负相关(均 P<0.05)。M 值与 CON 和 T2D 中的 ICIVGTT 呈正相关(r=0.199 和 r=0.178,均 P<0.05),与 CON 中的 ICMMT 呈正相关(r=0.176,P<0.05)。HCL 与 T2D(r=-0.005 和 r=-0.037)和 CON(r=-0.127 和 r=-0.058,均 P<0.05)中的 ICIVGTT 和 ICMMT 呈负相关。同样,T2D 或 CON 中有脂肪变性的患者的 ICMMT 低于无脂肪变性的患者(均 P<0.05)。
在诊断后 1 年内,T1D 和 T2D 中的胰岛素清除率均降低,但与肝脂质含量呈负相关,而在 T2D 中则更为明显。此外,胰岛素清除率在每种糖尿病类型中与血糖控制和胰岛素敏感性的相关性不同,这可能表明影响胰岛素动力学的特定机制不同。